Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mead Johnson Nutrition 1Q profit rises 21 percent
Yahoo/AP
Thursday, April 29, 2010 - 11:00am
tags:
Mead Johnson, earnings
Biota sees Relenza sales fall as swine flu fear fades
Reuters
Thursday, April 29, 2010 - 10:59am
tags:
Biota, RELENZA, Australia
HR Hell at Novartis: Alleged Rape Victim Threatened With "Disciplinary Action"
BNET Pharma
Thursday, April 29, 2010 - 10:40am
tags:
Novartis, discrimination, lawsuits
Talecris shares rise as profit tops Street
Bizjournals.com
Thursday, April 29, 2010 - 9:38am
tags:
Talecris, earnings
AstraZeneca quarterly profit rises 29%
Marketwatch
Thursday, April 29, 2010 - 9:34am
tags:
AstraZeneca, earnings
Bristol-Myers Squibb posts 16% growth in quarterly profit
Marketwatch
Thursday, April 29, 2010 - 9:31am
tags:
Bristol-Myers Squibb, earnings
Sanofi-Aventis boosted by vaccine sales
FT.com
Thursday, April 29, 2010 - 9:22am
tags:
Sanofi, earnings
Brazil court rules Viagra patent ends in June, year earlier than Pfizer argues
Yahoo/AP
Thursday, April 29, 2010 - 7:16am
tags:
Pfizer, patents, Viagra, Brazil
Roche’s Taspoglutide for Diabetes Meets Goal, Ipsen Says
Bloomberg
Thursday, April 29, 2010 - 7:15am
tags:
Ipsen, Roche, diabetes, taspoglutide
Pipeline Prospects: Bristol-Myers' Big Plans for New Drugs
BNET Pharma
Wednesday, April 28, 2010 - 6:28pm
tags:
Bristol-Myers Squibb, belatacept, Plavix, Apixaban, Avapro
Earnings Preview: Celgene Corp.
Seeking Alpha
Wednesday, April 28, 2010 - 6:14pm
tags:
earnings, Celgene
Merck promotes key VP to president, prelude to CEO's retirement next year
Yahoo/AP
Wednesday, April 28, 2010 - 6:08pm
tags:
Merck, Kenneth Frazier
Pfizer's Future: Biotech Follow-ups
Seeking Alpha
Wednesday, April 28, 2010 - 6:01pm
tags:
Pfizer, follow-on biologics
Public health advocate wants Avandia study halted
Yahoo/AP
Wednesday, April 28, 2010 - 5:49pm
tags:
GSK, Avandia, diabetes, Public Citizen, Sidney Wolfe
Earnings Preview: Merck
Yahoo/Zacks.com
Wednesday, April 28, 2010 - 5:45pm
tags:
Merck, earnings
Pfizer developing "bio-betters," seeking rare blood disorder drugs
Fierce Biotech
Wednesday, April 28, 2010 - 11:36am
tags:
Pfizer
BioCryst rallies on gout study; AMAG shares fall
Marketwatch
Wednesday, April 28, 2010 - 11:33am
tags:
Amag Pharmaceuticals, Biocryst, gout
Healthcare overhaul's price tag grows to $105B
Fierce Pharma
Wednesday, April 28, 2010 - 10:58am
tags:
healthcare reform
BioCryst 1Q loss narrows on peramivir revenue
Yahoo/AP
Wednesday, April 28, 2010 - 10:57am
tags:
Biocryst, earnings, peramivir
Jazz Enters Oversold Territory
Yahoo/Zacks.com
Wednesday, April 28, 2010 - 10:56am
tags:
Jazz Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.